Clinical analysis of 49 cases with invasive fungal infections in pediatric intensive care unit

Tao ZHANG; Yuhui WU; Weiguo YANG; Qing MENG; Baoxing HUANG; Yanxia HE.
Chinese Pediatric Emergency Medicine ; (12): 201-205, 2019.
Artículo en Zh | WPRIM | ID: wpr-743951

Documentos relacionados

  1. Liposomal amphotericin B-the present.
  2. Fungistatic Effect of Phthalide Lactones on <i>Rhodotorula mucilaginosa</i>.
  3. Existing and emerging therapies for the treatment of invasive candidiasis and candidemia.
  4. Predictors for Prolonged Hospital Stay Solely to Complete Intravenous Antifungal Treatment in Patients with Candidemia: Results from the ECMM Candida III Multinational European Observational Cohort Study.
  5. Echinocandins versus non-echinocandins for the treatment of invasive candidiasis: A meta-analysis of randomized controlled trials.
  6. Chronic Pulmonary Aspergillosis: Clinical Presentation and Management.
  7. Improving health literacy of antifungal use-Comparison of the readability of antifungal medicines information from Australia, EU, UK, and US of 16 antifungal agents across 5 classes (allylamines, azoles, echinocandins, polyenes, and others).
  8. Treatment of invasive candidiasis in the era of Candida resistance.
  9. Prevalence of Antifungal Resistance, Genetic Basis of Acquired Azole and Echinocandin Resistance, and Genotyping of Candida krusei Recovered from an International Collection.
  10. Dihydroazolopyrimidines: Past, Present and Perspectives in Synthesis, Green Chemistry and Drug Discovery.